Table 3.
Variable | Hazard ratio | 95% CI lower limit | 95% CI upper limit | P-value |
---|---|---|---|---|
Male sex | 1.14 | 0.19 | 6.88 | 0.89 |
Age, years | 1.06 | 0.96 | 1.17 | 0.26 |
Body mass, kg | 0.94 | 0.88 | 1.01 | 0.11 |
BMI, kg/m2 | 0.89 | 0.73 | 1.08 | 0.23 |
Smoking status | 0.53 | 0.10 | 2.75 | 0.45 |
Cigarette package years | 1.00 | 0.98 | 1.03 | 0.85 |
FEV1 | 0.19 | 0.00 | 11.64 | 0.43 |
FEV1 % predicted | 0.98 | 0.90 | 1.08 | 0.71 |
Estimated VO2 max, mL/min/kg | 0.85 | 0.57 | 1.28 | 0.45 |
Oxygen sat, at rest | 0.93 | 0.55 | 1.56 | 0.78 |
Oxygen supplement, yes | 2.53 | 0.81 | 7.95 | 0.11 |
CAT | 0.97 | 0.84 | 1.11 | 0.64 |
Number of previous exacerbations | 1.20 | 0.89 | 1.62 | 0.24 |
MRC | 2.59 | 0.67 | 10.00 | 0.17 |
COPD stage (GOLD) | 1.44 | 0.30 | 6.99 | 0.66 |
Comorbid cardiovascular disease | 2.72 | 0.45 | 16.32 | 0.27 |
Comorbid diabetes | 1.13 | 0.38 | 3.38 | 0.83 |
Number of hospitalizations from rehabilitation end +18 months | 1.17 | 0.85 | 1.62 | 0.34 |
Abbreviations: BMI, body mass index; CAT, COPD assessment test; CI, confidence interval; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; GOLD, Global Initiative for Chronic Obstructive Lung Disease; MRC, Medical Research Council.